Details

Industries

Biotechnology

Founded date

Jan 1, 2018

Operating Status

Active

Olimmune is a developer of groundbreaking oligonucleotide immunotherapies for treatment-resistant and metastatic cancers. Olimmune’s lead drug candidate, OLIM-01, is being developed for genitourinary and head and neck cancers.